» Articles » PMID: 19892241

Substrate-specific Derangements in Mitochondrial Metabolism and Redox Balance in the Atrium of the Type 2 Diabetic Human Heart

Overview
Date 2009 Nov 7
PMID 19892241
Citations 215
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The aim of this study was to determine the impact of diabetes on oxidant balance and mitochondrial metabolism of carbohydrate- and lipid-based substrates in myocardium of type 2 diabetic patients.

Background: Heart failure represents a major cause of death among diabetic patients. It has been proposed that derangements in cardiac metabolism and oxidative stress may underlie the progression of this comorbidity, but scarce evidence exists in support of this mechanism in humans.

Methods: Mitochondrial oxygen (O(2)) consumption and hydrogen peroxide (H(2)O(2)) emission were measured in permeabilized myofibers prepared from samples of the right atrial appendage obtained from nondiabetic (n = 13) and diabetic (n = 11) patients undergoing nonemergent coronary artery bypass graft surgery.

Results: Mitochondria in atrial tissue of type 2 diabetic individuals show a sharply decreased capacity for glutamate and fatty acid-supported respiration, in addition to an increased content of myocardial triglycerides, as compared to nondiabetic patients. Furthermore, diabetic patients show an increased mitochondrial H(2)O(2) emission during oxidation of carbohydrate- and lipid-based substrates, depleted glutathione, and evidence of persistent oxidative stress in their atrial tissue.

Conclusions: These findings are the first to directly investigate the effects of type 2 diabetes on a panoply of mitochondrial functions in the human myocardium using cellular and molecular approaches, and they show that mitochondria in diabetic human hearts have specific impairments in maximal capacity to oxidize fatty acids and glutamate, yet increased mitochondrial H(2)O(2) emission, providing insight into the role of mitochondrial dysfunction and oxidative stress in the pathogenesis of heart failure in diabetic patients.

Citing Articles

Understanding Diabetic Cardiomyopathy: Insulin Resistance and Beyond.

Binu A, Kapoor N Heart Int. 2025; 18(2):7-13.

PMID: 39885933 PMC: 11781369. DOI: 10.17925/HI.2024.18.2.2.


Mitochondrial Dysfunction in HFpEF: Potential Interventions Through Exercise.

Cui X, Spanos M, Zhao C, Wan W, Cui C, Wang L J Cardiovasc Transl Res. 2025; .

PMID: 39863753 DOI: 10.1007/s12265-025-10591-5.


Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications.

Caturano A, Rocco M, Tagliaferri G, Piacevole A, Nilo D, Lorenzo G Antioxidants (Basel). 2025; 14(1).

PMID: 39857406 PMC: 11759781. DOI: 10.3390/antiox14010072.


Epigenetic regulation and post-translational modifications of ferroptosis-related factors in cardiovascular diseases.

Jing C, Wu Y, Zhang Y, Zhu Z, Zhang Y, Liu Z Clin Epigenetics. 2025; 17(1):4.

PMID: 39799367 PMC: 11724467. DOI: 10.1186/s13148-024-01809-5.


Meta-analysis of the effects of different exercise modes on cardiac function and peak oxygen uptake in patients with type 2 diabetes mellitus.

Jianghua H, Feier M, Dong Z, Qiuying L, Ya W, Yan W Front Physiol. 2024; 15:1448385.

PMID: 39600919 PMC: 11588746. DOI: 10.3389/fphys.2024.1448385.


References
1.
Boudina S, Sena S, Theobald H, Sheng X, Wright J, Hu X . Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes. 2007; 56(10):2457-66. DOI: 10.2337/db07-0481. View

2.
Severson D . Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. Can J Physiol Pharmacol. 2004; 82(10):813-23. DOI: 10.1139/y04-065. View

3.
Rijzewijk L, van der Meer R, Smit J, Diamant M, Bax J, Hammer S . Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol. 2008; 52(22):1793-9. DOI: 10.1016/j.jacc.2008.07.062. View

4.
Madrazo J, Kelly D . The PPAR trio: regulators of myocardial energy metabolism in health and disease. J Mol Cell Cardiol. 2008; 44(6):968-975. DOI: 10.1016/j.yjmcc.2008.03.021. View

5.
Seppet E, Eimre M, Anmann T, Seppet E, Piirsoo A, Peet N . Structure-function relationships in the regulation of energy transfer between mitochondria and ATPases in cardiac cells. Exp Clin Cardiol. 2008; 11(3):189-94. PMC: 2276156. View